Emily Katz, MD
Anesthesiology · Kalamazoo, MINPI 1043732217
Payments from drug & device makers
What this record shows
Abbott accounts for 79.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,450 and has fallen 89.3% since, to $369 in 2025. Among anesthesiology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $80.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$5K
- Nevro Corp.$626
- Boston Scientific$380
- AbbVie$114
- Collegium Pharmaceutical, Inc.$75
- Globus Medical$57
- plus $74 from 4 others
What the payments were for
- Travel & lodging$3,31353%
- Food & beverage$2,99347%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 38 | $4,981 |
| Nevro Corp. | 11 | $626 |
| Boston Scientific | 13 | $380 |
| AbbVie | 6 | $114 |
| Collegium Pharmaceutical, Inc. | 4 | $75 |
| Globus Medical | 2 | $57 |
| Vertex | 1 | $20 |
| IBSA Pharma Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$2,672
- Proclaim IPG$1,364
- OCTRODE$261
- Senza Spinal Cord Stimulation System$247
- GENERAL PAIN MANAGEMENT$117
How this compares
$6,306 in reported general payments places this provider in the 95th percentile of 1,299 anesthesiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 29 | $641 |
| Gabapentin | 50 | $583 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $512 |
| Tramadol Hcl | 23 | $104 |
| Tizanidine Hcl | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Kalamazoo
- Neal DuggalAnn Arbor$206K
- John PappasRoyal Oak$112K
- Jay GlobersonSouthfield$79K
- David HovordAnn Arbor$48K
- Birgete WebbGrosse Pointe Park$28K
- Timothy KwiecienMarshall$27K
- Matthew McCordLansing$25K
- Zachary WeinermanDetroit$24K
- Bryan TomaRoyal Oak$22K
- Patrick McKearneyGrand Rapids$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.